Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy
Elizabeth R Hawkins, Reena R D’Souza, Astero Klampatsa Division of Cancer Therapeutics, The Institute of Cancer Research, London, UKCorrespondence: Astero KlampatsaThoracic Oncology Immunotherapy Group, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Su...
Guardado en:
Autores principales: | Hawkins ER, D'Souza RR, Klampatsa A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ebb64adc425b40b8aba3cb8d1d89150f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Sergey Kulemzin, et al.
Publicado: (2021) -
Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
por: Christopher Sloas, et al.
Publicado: (2021) -
Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies
por: Jessica Waibl Polania, et al.
Publicado: (2021) -
Adoptive chimeric antigen receptor T cell (CAR-T) and Treg cell-based immunotherapies: Frontier therapeutic aspects in cancers
por: Mehran Bahraini, et al.
Publicado: (2021) -
Immunosuppressive microenvironment in oral cancer: implications for cancer immunotherapy
por: Shalini K. Sureshbabu, et al.
Publicado: (2021)